Previous Conference Participation by RenaSci:

ASSOCIATION FOR THE STUDY OF OBESITY

Managing Appetite: Pharmaceuticals and Functional Foods Feb 2009
Institute of Child Health, London, UK
Bio-Behavioural Assays of Weight Control Agents: Assessing Effects on Satiety and Other Appetite Mechanism Prior to Clinical Research.

BRITISH PHARMACOLOGICAL SOCIETY Winter Meeting 2008

Hilton Brighton Metropole, Brighton, UK

Joint Symposium - Obesity and Metabolic Diseases SIG & Clinical Pharmacology Section
Organisers: Director (RenaSci Consultancy, UK) & Dr Albert Ferro (Kings College London, UK)
 

NEUROSCIENCE 2008

The 38th Annual Meeting of the Society for Neuroscience

Walter E. Washington Convention Center
Saturday to Wednesday 15-19th November, Washington, DC.
 

RenaSci hosted a trade stand at this meeting. We also presented or co-authored on the following posters:

SLV-313: In vivo occupancy of D2 and 5-HT1A receptors by this dual acting D2 receptor antagonist/5-HT1A agonist antipsychotic candidate

SLV-313: A dual acting D2 receptor antagonist/5-HT1A agonist improves glutamatergic-induced memory impairment and demonstrates anxiolytic- and antidepressant-like effects in rodents
Poster number 155.16/CC4; Sunday 16th November, 11:00 -12:00

Pharmacology of AMR-MCH-1, a MCH1 receptor antagonist for the treatment of obesity
Poster number 584.25/SS6; Tuesday 18th November, 08:00 - 09:00

Effect of rimonabant on body weight, glucose tolerance, body composition and lipolysis in fa/fa Zucker rats: a comparison with pair-fed controls

Development and validation of a radioligand receptor binding assay for MCH1 receptors using [3H]AMR-MCH-1 in vitro and ex vivo

Prevention of antipsychotic-induced weight-gain by the 5-HT6 agonist, E-6837

Effect of the MCH1 antagonist, GW803430, on body weight, food and water intake, glucose tolerance, fat pad weight, ex vivo binding and various plasma parameters in dietary-induced obese C57BL/6J mice
 

VISIONGAIN COLLOQUIUM ON OBESITY DRUG DEVELOPMENT 2008

13th - 14th October, London, UK
Presentation - Analysing the growing potential for pharmaceuticals to reduce the spread of obesity in a global market
Director, RenaSci Consultancy
 

IBC PHARMACEUTICAL LAW FOR PATENT ATTORNEYS AND IP SPECIALISTS 2008

6 October, London, UK
Presentation - The R & D drug development programme: from the bench to the marketplace
Director, RenaSci Consultancy
 

SMR –SOCIETY FOR MEDICINES RESEARCH 2008

Obesity and its Treatment
25th September, London, UK
Presentation - Discovery and development of anti-obesity drugs: a case study
Director, RenaSci Consultancy
 

SMI CONFERENCES - METABOLIC DISEASES 2008

24-25th September, London, UK
Presentation - Emerging CNS approaches to obesity treatment
Director, RenaSci Consultancy
 

SEROTONIN CLUB – EPHAR 2008 Satellite Meeting

17-20th July, Oxford, UK
Symposium - Serotonergic approaches to novel antipsychotics
Organised and Chaired by one of our Directors